Will seek regulatory approval
Good news for parents worried about sending their kids to school amid the pandemic.
Pfizer announcing today its COVID-19 vaccine works for children ages 5 to 11.
The next step is getting approval from regulators in the U.S.. Britain and Europe to begin with.
Pfizer studied the vaccine in more than 2,000 kindergartners and elementary school-aged kids.
It gave them about a third of the typical dose and found they developed antibody levels just as strong as teens and young adults.

Region Trims More from Budget
Cold Weather Policy for Homeless Not Changing
Niagara Falls Handling Salt Shortage
Man Killed in Tent Fire
Region Updated on Measles Outbreak
St. Catharines Draws X Through X
Police Looking for Laundry Thief
Toronto Man Charged with Trafficking